Hormone Therapy, Radiation Therapy, and Steroid 17alpha-monooxygenase TAK-700 in Treating Patients With High-Risk Prostate Cancer

Hormone Therapy, Radiation Therapy, and Steroid 17alpha-monooxygenase TAK-700 in Treating Patients With High-Risk Prostate Cancer

Sponsors and Collaborators
Radiation Therapy Oncology Group
National Cancer Institute (NCI)

Principal Investigator
M. Dror Michaelson, MD, PhD, Massachusetts General Hospital

ClinicalTrials.gov Identifier
NCT01546987

Loading links....
You must be a registered member of Renal and Urology News to post a comment.

Sign Up for Free e-newsletters